1. Home
  2. HUBC vs HOWL Comparison

HUBC vs HOWL Comparison

Compare HUBC & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hub Cyber Security Ltd.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$2.20

Market Cap

25.0M

Sector

N/A

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.66

Market Cap

29.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBC
HOWL
Founded
2017
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0M
29.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HUBC
HOWL
Price
$2.20
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
174.7K
423.0K
Earning Date
05-01-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,966,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.06
$0.53
52 Week High
$159.00
$2.38

Technical Indicators

Market Signals
Indicator
HUBC
HOWL
Relative Strength Index (RSI) 49.27 47.92
Support Level $2.06 $0.59
Resistance Level $2.80 $0.74
Average True Range (ATR) 0.36 0.07
MACD -0.13 0.01
Stochastic Oscillator 15.76 31.78

Price Performance

Historical Comparison
HUBC
HOWL

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: